Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Fleissner

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Cancer Research|January 28, 2004
Identification and clinical relevance of receptor activator of nuclear factor kappaB ligand expression of myeloma cellsUlrike Heider, Ivana Zavrski, Christian Jakob, et al.
British Journal of Haematology|April 30, 2003
Circulating hepatocyte growth factor levels in multiple myelomaChristian Jakob, Claudia Fleissner, Ivana Zavrski, et al.
European Journal of Haematology|August 22, 2003
Bisphosphonates in early multiple myelomaOrhan Sezer, Christian Jakob, Ivana Zavrski, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|July 5, 2007
Molecular and clinical aspects of proteasome inhibition in the treatment of cancerIvana Zavrski, Christian Jakob, Martin Kaiser, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 2006
Bone markers in multiple myelomaUlrike Heider, Claudia Fleissner, Ivana Zavrski, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2006
Angiogenesis in multiple myelomaChristian Jakob, Jan Sterz, Ivana Zavrski, et al.
Haematologica|February 8, 2006
The effects of the histone deacetylase inhibitor valproic acid on cell cycle, growth suppression and apoptosis in multiple myelomaMartin Kaiser, Ivana Zavrski, Jan Sterz, et al.
Anti-Cancer Drugs|April 23, 2005
Proteasome: an emerging target for cancer therapyIvana Zavrski, Christian Jakob, Peter Schmid, et al.
European Journal of Haematology|December 14, 2005
Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphomaUlrike Heider, Martin Kaiser, Jan Sterz, et al.
European Journal of Haematology|February 14, 2004
Treatment of refractory chronic lymphocytic leukemia with Campath-1H in combination with lamivudine in chronic hepatitis B infectionUlrike Heider, Claudia Fleissner, Ivana Zavrski, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Cancer Research|January 28, 2004
Identification and clinical relevance of receptor activator of nuclear factor kappaB ligand expression of myeloma cellsUlrike Heider, Ivana Zavrski, Christian Jakob, et al.
British Journal of Haematology|April 30, 2003
Circulating hepatocyte growth factor levels in multiple myelomaChristian Jakob, Claudia Fleissner, Ivana Zavrski, et al.
European Journal of Haematology|August 22, 2003
Bisphosphonates in early multiple myelomaOrhan Sezer, Christian Jakob, Ivana Zavrski, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|July 5, 2007
Molecular and clinical aspects of proteasome inhibition in the treatment of cancerIvana Zavrski, Christian Jakob, Martin Kaiser, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 2006
Bone markers in multiple myelomaUlrike Heider, Claudia Fleissner, Ivana Zavrski, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2006
Angiogenesis in multiple myelomaChristian Jakob, Jan Sterz, Ivana Zavrski, et al.
Haematologica|February 8, 2006
The effects of the histone deacetylase inhibitor valproic acid on cell cycle, growth suppression and apoptosis in multiple myelomaMartin Kaiser, Ivana Zavrski, Jan Sterz, et al.
Anti-Cancer Drugs|April 23, 2005
Proteasome: an emerging target for cancer therapyIvana Zavrski, Christian Jakob, Peter Schmid, et al.
European Journal of Haematology|December 14, 2005
Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphomaUlrike Heider, Martin Kaiser, Jan Sterz, et al.
European Journal of Haematology|February 14, 2004
Treatment of refractory chronic lymphocytic leukemia with Campath-1H in combination with lamivudine in chronic hepatitis B infectionUlrike Heider, Claudia Fleissner, Ivana Zavrski, et al.
Pageof 2